Xiangsheng Medical: Independent Innovation Achieves Leading Position in Ultrasound Medical Imaging Equipment

Wuxi Xiangsheng Medical Technology Co., Ltd. focuses on the research, development, manufacturing, and sales of ultrasound medical imaging equipment, providing various ultrasound medical imaging equipment and professional technical development services with complete independent intellectual property rights to medical institutions, research institutions, and strategic partners at home and abroad. The company has gradually made breakthroughs in the research and development of technologies such as breast three-dimensional ultrasound volumetric imaging systems, high-end cardiac ultrasound diagnostic systems based on artificial intelligence and new material probes, and low-power portable ultrasound diagnostic systems, breaking the monopoly of foreign products in the high-end specialized ultrasound technology. According to the different economic development levels of countries around the world, the company has launched differentiated products covering high, medium, and low ends. After years of cultivation in the international market, it has sold ultrasound equipment in more than 100 countries and regions worldwide, becoming one of the leading manufacturers of ultrasound medical imaging equipment globally.

Adhering to Independent R&D and Innovation, Mastering Multiple Core Technologies

As a high-tech enterprise, Xiangsheng Medical has always adhered to the technological concept of independent research and development. It has now mastered the full set of core technologies of ultrasound medical imaging, from 2D, 3D, and 4D ultrasound to probe core components, image processing algorithms, image analysis software, and complete machine design and development; from clinical application specialization and equipment portability to artificial intelligence cloud platform solutions. In terms of color ultrasound technology, the company has mastered 32 major core technologies, including harmonic imaging technology, cardiac blood flow wall filtering technology, microvascular blood flow imaging algorithm, ultra-low-power hardware system bottom optimization technology, and breast three-dimensional ultrasound volumetric imaging system, and reserves related technologies such as ultrasound artificial intelligence multi-disease auxiliary diagnosis core algorithm, medical cloud platform, and big data analysis technology. In terms of ultrasound probe technology, the company has made significant breakthroughs in probe high-attenuation backing, low-attenuation matching layer sound-transmitting materials, low-attenuation lens materials, new piezoelectric materials and 1-3 piezoelectric composite materials, and single-crystal materials, further improving the performance of the probes and achieving a leap in image quality. The company's probes cover various types, including cardiac probes, abdominal probes, small organ probes, obstetrics and gynecology probes, urology probes, intraoperative probes, dual-plane probes, multi-dimensional probes, and volumetric probes, and cover a frequency range of 1-23 MHz. The probes are characterized by high sensitivity, high reliability, large bandwidth, and good consistency, and can meet the clinical applications of numerous organs and tissues in the human body. The company owns complete independent intellectual property rights for color ultrasound and has obtained 177 authorized patents, including 42 Chinese invention patents and 5 foreign invention patents; it has obtained 63 software copyrights and is a "National Intellectual Property Advantage Enterprise". The company's technical level is industry-leading, and it has undertaken many national and provincial and ministerial projects or topics, including the "Thirteenth Five-Year Plan" national key research and development plan, the "Twelfth Five-Year Plan" national science and technology support plan, and the national Torch Plan.

Rich Variety and Reliable Quality; Products Sold Worldwide

After years of development, Xiangsheng Medical has formed a rich product system, successively researching and mass-producing multiple product series covering whole-body clinical applications. It can meet the needs of a broad range of segmented markets. Its products have been selected multiple times for national key product promotion and guidance lists and catalogs, such as "National High-tech Products," "National Key New Products," and "Excellent Domestic Medical Equipment Product Catalog." Product performance is widely recognized by the market, and products have been exported to more than 100 countries and regions at home and abroad. The company has strong product development and production process advantages, capable of rapidly transforming technological advantages into product advantages, with the ability to quickly mass-produce new products, achieve high yield rates, maintain stable performance, achieve low production costs, and ensure safety and compliance. Products have successfully obtained FDA registration and CE certification. The company strictly controls product quality and adheres to "R&D-driven quality assurance." By establishing a quality center, it ensures that the entire product development process strictly follows international and domestic quality system standards and regulations. It obtained CE, FDA, and Canadian international certifications or registrations relatively early, allowing its products to enter the European and American markets and win strategic cooperation from internationally renowned medical device companies. The company strives to build a perfect Sales Network, establishing a global sales network covering more than 100 countries and regions in North America, Europe, Asia, Africa, Latin America, and the Middle East. In the domestic market, the company has established a nationwide sales network, with products covering more than 30 provinces, autonomous regions, and municipalities. The company attaches importance to product After-sale Service, and has built its own after-sale service advantages in various aspects, such as after-sales repair solutions, distributor management, and daily Customer Service.

The successful implementation of the fundraising project will further increase the company's product capacity, improve product quality, strengthen core technology reserves, enhance product technology added value, and enhance the breadth of market marketing coverage and Brand influence. Xiangsheng Medical will take this listing on the Sci-Tech Innovation Board as an opportunity to continue to adhere to customer clinical needs as its guide and technological innovation as its core competitiveness, gradually enhance its R&D capabilities, continuously enrich product types, expand Applications, and vigorously expand the boundaries of the integration of AI and ultrasound medical imaging, striving to solve clinical pain points, create value for customers, and strive to become a world-leading provider of high-end ultrasound medical imaging equipment and services.